How many insider trades does FilingIQ track for OGEN?

FilingIQ tracks 91 Form 4 insider transactions for OGEN (ORAGENICS INC), covering filings from Mar 16, 2015 onwards. 1 of those were filed in the last 90 days.

Are OGEN insiders net buyers or net sellers?

Across the full Form 4 history for OGEN, 23 transactions (25%) were open-market purchases and 30 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OGEN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OGEN in?

ORAGENICS INC (OGEN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.88M.

OGEN insider trading

NYSE American Healthcare

ORAGENICS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

25% / 33%

Market cap

$2.88M

About ORAGENICS INC

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and lantibiotics. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Sarasota, Florida.

Company website: www.oragenics.com

OGEN insider activity at a glance

FilingIQ has scored 91 insider transactions for OGEN since Mar 16, 2015. The most recent filing in our index is dated Jul 1, 2026.

Across the full history, 23 open-market purchases and 30 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OGEN insider trades is 57.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OGEN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,099

UNITED THERAPEUTICS Corp

APLS 274

Apellis Pharmaceuticals, Inc.

KYMR 232

Kymera Therapeutics, Inc.

GH 194

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for OGEN?: FilingIQ tracks 91 Form 4 insider transactions for OGEN (ORAGENICS INC), covering filings from Mar 16, 2015 onwards. 1 of those were filed in the last 90 days.
Are OGEN insiders net buyers or net sellers?: Across the full Form 4 history for OGEN, 23 transactions (25%) were open-market purchases and 30 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OGEN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OGEN in?: ORAGENICS INC (OGEN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.88M.

Methodology & sources

Every OGEN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.